Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. My Approach to Bifurcation Disease - Master\'s Skill Secret
  2. CTO Revascularization 2022: Guidelines and Concept Change
  3. Physiologic Approach For Non-LM Bifurcation Disease
  4. Unmet Need for FFR in LM PCI
  5. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  6. 타비 시술을 위한 CT 평가
  7. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  8. FFR is a Routine Cath Lab Procedure
  9. FFR, It\'s Standard
  10. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  11. Updated Imaging/Physiology-Guided PCI Tuning 2021
  12. Under Pressure: Optimal Post-Dilation Strategy
  13. Difficult Wiring, Tips and Tricks
  14. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  15. Imaging-guided PSP for Optimizing PCI
  16. How to Treat Tandem Lesion Under Physiology-Guidance
  17. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  18. Post TAVR Coronary Access with Evolut System
  19. Self-Expandable Evolut R & PRO Valve
  20. TAVR for Bicuspid AV: Tips and Tricks
  21. Bifurcation PCI: Contemporary Practical Approach
  22. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  23. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  24. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  25. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  26. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  27. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  28. Current Status of Balloon-Expandable TAVR in Korea
  29. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  30. TAVR for Bicuspid AV: Tips and Tricks
  31. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  32. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  33. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  34. Expert Case Review: Complex Bifurcation PCI
  35. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  36. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  37. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  38. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  39. How About Integrated Use of Resting Pd/Pa and FFR?
  40. Distal Left Main Bifurcation PCI: Concept Is More Important.
  41. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  42. FFR as the Gold Standard Index!
  43. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  44. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  45. Asian Pacific TAVR Registry
  46. [Taped Case] TAVR with Evolut R
  47. Bicuspid AS: Future Perspectives of TAVR
  48. Integrated Use of FFR and IVUS for LM PCI
  49. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  50. Bicuspid and Valve-in-Valve; How Different?
  51. Clinical Outcome of DEFER
  52. Left Main and MVD PCI: Imaging and Functional Guidance
  53. Utility of Intravascular Imaging for Resolving Issues During PCI
  54. Long Lesion and Tandem Lesion
  55. Bicuspid TAVR Registry
  56. AP TAVR Registry
  57. Current Status of TAVR: High/Intermediate and Lower Risk
  58. Clinical Impact of Routine FFR Measurement
  59. Tandem
  60. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  61. Practical Aspect of IMR in AMI and Stable Angina
  62. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  63. Elderly Population
  64. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  65. [Review in 2015] Physiology
  66. Tandem Lesion Evaluation
  67. Integrated Use of IVUS and FFR in Real Practice
  68. Readmission After PCI or CABG
  69. Left Main
  70. Final Answer RESTORE
  71. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  72. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  73. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  74. Preliminary Data from IRIS FFR Registry
  75. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  76. Left Main PCI
  77. Understanding About Visual-Functional Mismatching
  78. TAVI for Bicuspid Valve Stenosis
  79. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  80. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  81. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  82. Clinical Implementation of FFR
  83. Case-based Review: Incidence and Treatment of LM ISR
  84. LM & Tandem Lesion
  85. VH IVUS: Native Plaque and Neointima
  86. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  87. LM PCI
  88. IRIS-ELEMENT Data Review
  89. Cross and Perfect: 2013 Update
  90. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  91. Anatomical - Functional Stenosis: How Much Discordant?
  92. Case Presentation: Functional Angioplasty
  93. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  94. Novice's Trial of Complex LM PCI
  95. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  96. FFR Utilization in LM PCI
  97. Promus Element Clinical Program in Asan Medical Center
  98. FFR-guided PCI in Tandem Lesion
  99. Two Cases with Coronary Thromboembolism
  100. FFR Guided Functional Angioplasty
  101. Does the Timing of IABP Matter?